RE: PK models for rich and sparse sampling
From: Paul Hutson prhutson@pharmacy.wisc.edu
Subject: RE: [NMusers] PK models for rich and sparse sampling
Date: Tue, June 1, 2004 10:11 am
Mark:
The use of PRIOR at GSK and by others (DM) suggests that it is a powerful tool that
increases the Bayesian modelling capacity of NONMEM. Although I have a copy, it is
unclear to me that its use would be acceptable to reviewers in a manuscript, since it
is not a documented subroutine. Have any others been successful in using PRIOR in manuscripts?
More importantly (Bill), is there any hope in obtaining "official" recognition and documentation of PRIOR?
Paul
Paul Hutson, Pharm.D.
Associate Professor (CHS)
UW School of Pharmacy
777 Highland Avenue
Madison, WI 53705-2222
Tel: (608) 263-2496
FAX: (608) 265-5421
Pager: (608) 265-7000, #7856